Alerts
Midazolam Hydrochloride and Furosemide - Potential for Error
August 10, 2009
Healthcare providers are concerned about the potential for mix-up between Hospira brand midazolam hydrochloride 1 mg/mL injection 5 mg vials and Hospira brand furosemide 10 mg/mL injection 40 mg vials (see picture). The two products both have orange colored caps, are similar in size, and are used in a similar setting.
Recommendations for preventing medication errors include the following:
- Encourage staff to read drug labels prior to compounding any intravenous admixtures requiring either of these agents.
- Store the solutions in separate areas.
Updated
August 10, 2009; University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.
